Filter by:

Project name

Lead Institution



St George's Vaccine Institute
A phase 3 trial to evaluate the efficacy and safety of a recombinant spike protein nanoparticle vaccine in adults.
St George's Vaccine Institute
This trial will compare vaccines that are currently being used for the UK vaccination programme, as well as new vaccines as they are approved, in low-risk pregnant women aged 18-45 years-old and between 13-34 weeks gestation.
University of Glasgow
The OCTAVE trial is a multi-centre, multi-disease, prospective observational cohort trial to investigate the effectiveness of COVID-19 vaccines in clinically at-risk patient groups.

National Institute for Health Research (NIHR), UK Research and Innovation (UKRI)

Imperial College London
The purpose of this trial is to evaluate whether a new self-amplifying ribonucleic acid (RNA) COVID-19 vaccine candidate is safe and whether it produces immune responses against SARS-CoV-2.

Medical Research Council, via UK Research and Innovation.